Pregnancy Hypertension· 2026Q1
Hospital readmissions and blood pressure management in the early postpartum period following hypertensive disorders of pregnancy
- 0citations
- Q1SCImago
- 2026year
Short summary
Severe postnatal hypertension (≥160/110 mmHg) affected 39% of women with a history of hypertensive disorders of pregnancy (HDP), leading to readmissions in 29% of cases, with amlodipine showing a significant reduction in readmissions and faster BP decline compared to no treatment or labetalol.
AI-generated from the title and abstract; the full text is not read.
Key points
- 39% of women with HDP experienced severe postnatal hypertension (≥160/110 mmHg).
- 29% of women required at least one readmission to maternity triage.
- Blood pressure peaked five days postpartum, with median discharge occurring on day three.
- Amlodipine was associated with lower odds of readmission (OR 0.58) and faster early BP decline compared to no treatment or labetalol.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background Hypertensive disorders of pregnancy (HDP) affect 8–10% of pregnancies. They are an important cause of maternal morbidity, with crucial implications for long-term cardiovascular health. Whilst antenatal blood pressure (BP) management is well described and evidence-based, postnatal treatment thresholds are higher, management varies, and supporting evidence is limited. Objectives To characterise postnatal BP trajectories in women with HDP and assess the prevalence of severe hypertension and emergency hospital presentation. Study Design and Main Outcome Measures. A retrospective cohort study used routinely collected NHS data from three maternity sites from women exposed to antihypertensive medication either during pregnancy, or within six weeks postpartum. 15,884 BP readings from 570 women were analysed between May and November 2024. Mixed regression models assessed blood pressure trajectories across the treatment groups. Results Severe postnatal hypertension (≥160/110 mmHg) occurred in 39% of women. 29% required ≥1 readmission to maternity triage. Antihypertensives prescribing at discharge was highly variable, with 28 regimens used; 38% of women were discharged without antihypertensive medication. BP peaked five days postpartum, whereas the median discharge occurred on day three. Amlodipine was associated with lower odds of re-admission compared with no treatment (OR 0.58 [95% CI 0.35–0.94]) and labetalol (0.54 [0.50–0.58]), and with a faster early BP decline ( p < 0.001). Conclusion Postnatal hypertension following HDP is common and remains a major driver of re-attendance. Differences in BP profiles by discharge medication suggest that antihypertensive choice influences early postnatal outcomes. Prospective studies and trials are needed to inform prescribing practices and to reduce morbidity.
The authors' abstract, as published at the source. Pregnancy Hypertension, 2026 · DOI ↗
The rest is in the Pofolia app
Takeaways and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Obstetrics and Gynecology
Obstetrics and GynecologyMedicine